Aclaris Therapeutics, Inc. announced the appointment of Gail Cawkwell, MD, PhD, as Chief Medical Officer, effective June 27, 2022. Dr. Cawkwell is a pediatric rheumatologist and epidemiologist who brings over 20 years of pharmaceutical development and medical affairs experience in large and small companies, and across multiple disease areas. Most recently, she served as Senior Vice President, Medical Affairs, Safety & Pharmacovigilance at Intercept Pharmaceuticals, Inc. Prior to that, Dr. Cawkwell worked for Purdue Pharma L.P. most recently as Special Advisor to the Board of Directors, and Pfizer Inc., most recently as Vice President Medicine Team Lead for Pfizer's tofacitinib franchise.

Dr. Cawkwell also previously served as a Clinical Instructor of Pediatrics at Columbia Presbyterian Health Center.